Atrial Fibrillation Market Expected To Boost The Industry Across The Globe

 Market Highlights

The global atrial fibrillation market is estimated to account for USD 11123.8 million and registering a CAGR of ~ 11.2 %. Atrial fibrillation is a disorder of the pace or the rhythm of the heart. It is caused by unsystematic electrical activity in the atria of the heart, which causes rapid stimulus of the ventricles, leading to an irregular heartbeat. Numerous factors such as advancements in minimally invasive surgeries to treat atrial fibrillation, appropriate and timely intervention of the healthcare delivery systems, and increased incidence rates of the risk factors are expected to drive the growth of the market during the forecast period. According to the Centers for Disease Control and Prevention, Atrial fibrillation (AFib) costs the United States about USD 6 billion annually. Medical costs for people who have AFib are about USD 8,705 higher per year than for people who do not have AFib. Therefore, the ability of the specialist to suspect and diagnose the condition is very important. The lack of technical knowledge and misdiagnosis and mismanagement of the condition may hamper the market growth.

The global atrial fibrillation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2017, Abbott completed the acquisition of St. Jude Medical, Inc. St. Jude Medical's strong positions in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain balance Abbott's leading positions in coronary interventions and mitral valve disease and will further create a strong and diverse product portfolio.

Access Report @ https://www.marketresearchfuture.com/reports/atrial-fibrillation-systems-market-6520 

Regional Analysis

The market in the Americas is expected to dominate the global atrial fibrillation market during the forecast period due to the escalation in the adoption of advanced technologies and procedures for the treatment of atrial fibrillation, and well-developed healthcare infrastructure. According to the Centers for Disease Control and Prevention in 2017, an estimated 2.7–6.1 million people in the United States have atrial fibrillation (AFib). The European market is expected to be the second-largest due to government funding and support of the healthcare sector. Also, many companies are setting up their research and development centers in this region, which will boost the market growth in this region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income, and huge population susceptible to cardiovascular diseases. The market in the Middle East & Africa is likely to account for the smallest share of the global atrial fibrillation market.

Segmentation

The global atrial fibrillation market has been segmented into type, treatment, and end-user.

The market, on the basis of type, has been segmented into paroxysmal atrial fibrillation, persistent atrial fibrillation, and permanent atrial fibrillation.

The permanent type of atrial fibrillation is anticipated to hold the largest share as it is the most common type of AFib with a high occurrence rate. The persistent atrial fibrillation segment is estimated to be the fastest growing owing to increased recurrence rates in patients.

The market, on the basis of treatment, has been segmented into medications, non-surgical procedures, and surgical procedures.

The market, based on medications, has been segmented blood thinners, rate controllers, and rhythm controllers.

The market, based on non-surgical procedures, has been segmented into electrical cardioversion and catheter ablation.

The market, based on surgical procedures, has been segmented into pacemaker implantation and open-heart maze procedure.

Key Players

Some of the key players in the global atrial fibrillation market are Medtronic Plc, Johnson & Johnson Services, Inc., Abbott, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Koninklijke Philips N.V., AtriCure, Inc., CardioFocus, Osypka AG, Siemens AG, Biosense Webster, Inc., Sichuan Jinjiang Electronic Science and Technology Co., Ltd., CathRx Ltd., and Vanguard AG.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Nurse call systems Market Study, Competitive Strategies, Key Manufacturers, New Project Investment And Forecast 2023

 Nurse call systems are required for alerting the nurses in case of medical emergency or need for care. Market Research Future (MRFR) has published and released a research report about the global nurse call system market that supposes progress for this market at 9.5% CAGR (Compound Annual Growth Rate) during the forecast period between 2018 and 2023. 

FREE SAMPLE COPY OF “Nurse Call System Market Research Report- Global forecast till 2023”@ https://www.marketresearchfuture.com/sample_request/5631 

The primary factors endowing the growth of the global nurse call system market include the growing geriatric population and the rising complexity of hospital operations. Other factors helping the market growth include favorable healthcare investments by government and the rising demand for better technological advancements. However, huge installation cost and stringent government regulation can harm the market growth during the forecast period.

The global nurse call system market can be segmented on the basis of applications, end users, technology, type, and lastly, region. With regards to application-based segmentation, this market has been segmented into alarms, medical emergency, workflow management, and others.

Based on end users, the market has been segmented into ambulatory care centers, assisted living centers, hospitals & nursing homes, and others. During the forecast period, hospitals & nursing homes are expected to hold the largest market share due to the rising number of private and public hospitals. Assisted living centers segment is expected to emerge as the fastest growing market segment due to the increase in the geriatric population and the rising need of such assisted living centers.

The technology-based segmentation segments the market into wired systems and wireless systems. By type, the market has been segmented into nurse call buttons, nurse call intercoms, nurse call integrated communication systems, nurse call mobile systems, and others. 

Key Players

The key players in the global nurse call system market include AMETEK Inc. (USA), Ascom (Switzerland), Austco Communication Systems Pty Ltd. (Australia), Azure Healthcare (Australia), BEC Integrated Solutions (USA), Cornell Communications (India), CSINC (India), Honeywell International Inc. (USA), Hill-Rom Services Inc. (USA), Jeron Electronic Systems Inc. (USA), Johnson Controls (USA), STANLEY Healthcare (USA), Systems Technologies (USA), Vigil Health Solutions Inc. LLC (USA), and West-Com Nurse Call System Inc. (USA). 

The regional segmentation of the global nurse call system market can segment the market into regional markets namely the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). Due to the availability of advanced medical facilities, government funding for research & development (R&D), and the presence of prominent market players, North America is a bigger regional market than South America. In North America, the USA and Canada are the most important country-specific markets. Argentina and Brazil are two strong economies that have the potential to grow as suitable markets.

You Can also read about covid19 Impact on this market @ 

Europe is another important regional market. Due to the economic reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. The influential country-specific markets in Europe are France, Germany, Italy, Spain, and the UK, followed by the remaining countries of Western Europe and Eastern Europe.

The Asia Pacific is the third most important regional market due to the emerging healthcare infrastructure and growing medical tourism in countries like IndiaOther important country-specific markets in this region are Australia, China, Japan, and South Korea, followed by the remaining countries in the Asia Pacific region.

In the MEA region, the market is small and limited due to poor countries, lack of awareness, lack of advanced medical facilities, low standard of medical facilities, lack of education, lack of healthcare facilities, and most governments not considering healthcare a priority.

Latest Industry News

• Wake Forest Baptist Health has deployed Vocera technology, developed by Vocera Communications Inc., to a hospital in order to elevate patient & staff experience, enhance patient surveillance, improve clinical workflows, and integrate nurse call systems. 12 DEC 2018

• Adena Regional Medical Center (ARMC) in Chillicothe, Ohio has successfully deployed Nurse Call System & Real-Time Location Service (RTLS), developed by Critical Alert Systems, a leading provider of patient communications solutions for hospitals and health systems. 22 AUG 2018

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Browse Complete Report With Toc @ https://www.marketresearchfuture.com/upcoming-reports/nurse-call-system-market-5631 

Animal Genetics Market Analysis, Industry Growth, Demand, Size, Share, Opportunities and Regional Forecast 2023

 Market Analysis 

The global animal genetics market is projected to grow exponentially at an alluring 8.4% CAGR over the predicted years (2018-2022). Animal genetics lays emphasis on the different facets of animal heredity which is the traits that passes from generation to generation. This field encompasses topics including animal breeding, genetic testing and genetic variability. Animal genetics utilizes twin techniques of general genetics, ontogenetic, mathematical-statistical, cytological, population and hybrid. On the commercial level, it is utilized for services such as genetic disease testing, DNA typing and genetic trait testing. 

 

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7004 

 

There are many factors that is driving the growth of the animal genetics market. Some of these factors as per the Market Research Future (MRFR) report include increasing consumption of protein that is animal-derived, rapid urbanization the world over, growing population, increasing use of advanced genetic technologies and genetic services for quality breeds and larger-scale production, rising focus to identify superior breeds, high investments in research and development activities, expansions undertaken by the leading players, rapid increase in animal diseases, increasing trend to possess companion animals, and increasing prevalence of various zoonotic diseases which boosted the demand for genetic testing. On the contrary, factors such as scarcity ok skilled experts in veterinary research, lack of technicians to conduct advanced genetic services, soaring price of animal testing, strict regulatory framework and negative effects to use genetic engineering on various animals may hinder the growth of animal genetics market.

 

Market Segmentation 

Market Research Future report offers an all-inclusive segmental analysis of the animal genetics market on the basis of animal genetic products, services and end-user. 

 

Based on animal genetic products, it is segmented into live animals and genetic materials. The genetic materials are further segmented into embryo and semen and the live animals are further segmented into canine, porcine, bovine, poultry and others. Of these, bovine semen is likely to have the maximum share in the market over the predicted years. 

 

Based on services, the animal genetics market is segmented into gene trait tests, DNA typing, genetic disease tests and others. Of these, genetic disease tests will lead the market over the predicted years. 

 

Based on end-user, it is segmented into research centers and institutes, diagnostic centers, veterinary hospitals and clinics and others. 

 

Regional Analysis 

Based on region, the animal genetics market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will sway the market over the predicted years due to growing use of animal genetics in research and rising acquisition by market players. Europe grabs the second largest position in the animal genetics market owing to high consciousness concerning the wellbeing of animals and rising investment on the region’s veterinary services. In the APAC region, the animal genetics market is expected to grow at the highest CAGR owing to increasing veterinary care services at the community level as well as the veterinary hospital. On the other hand, the animal genetics market in the Middle East and Africa will have a minimal share owing to scarcity of trained healthcare professionals and low per capita income. There however has been a boost in the demand for consistency and accuracy by the government and the end-users here that is increasing the use of the animal genetic technology. 

 

Key Players 

Key players profiled in the animal genetics market include vetGen (US), Alta Genetics (US), Animal Genetics (US), Envigo (US) Hendrix Genetics BV (The Netherland), Zoetis (US), Topigs Norsvin (Netherlands), CRV Holding B.V. (The Netherland), Groupe Grimaud (France), EW Group (Germany), URUS (US), Genus (UK), Neogen Corporation (US), and others.

Feb 2019- Wisdom Health, a popular dog genetic testing company has introduced an affordable DNA kit that works as human DNA tests. This test will not read the complete genome but will check definite number of markers. The company will compare the genetic information of a dog in their database with many other dogs. Here algorithm will be involved. 

 

Read Complete Report @ https://www.marketresearchfuture.com/reports/animal-genetics-market-7004 

Cannula Market Growth, Demand, Segmentation, Trends, Industry Size, Share and Forecast till 2023

 As per Market Research Future (MRFR) analysis, the global cannula market held a valuation of USD 113 million in 2017. It is estimated to grow at a CAGR of 6.7% from 2017 to 2023 (forecast period).

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6937 

Cannula is a bendable hollow tube with a retractable, sharp inner core. It is placed into a patient's vein or artery or other body cavities for the removal or delivery of fluids during surgery or medical examinations, such as infusion of medication or blood samples collection.

Cannula Market Dynamics

The demand for surgical procedures is increasing all over the world as surgery has become standard treatment for various health conditions. It is acknowledged that the growing number of surgical procedures is a significant driver of the cannula market. As per the Australian Institute of Health and Welfare, there were 10.6 million hospitalizations in 2015–16 and 1 in 4 hospitalizations involved surgery.

Numerous other factors such as increasing demand for cannulas for ocular surgeries, expanding healthcare infrastructure, and growing research & development activities related to healthcare, are also anticipated to fuel the growth of the market. As stated in the Indian Journal of Opthalmology in 2017, J-shaped cannula has shown good surgical results in cortex removal techniques.

However, stringent government regulations and a lack of qualified or trained physicians can hinder the growth of the market over the forecast period.

Cannula Market Segmentation

The global market for cannula has been segmented into product, material, application, and end-user.

Based on the product, the global market for cannula has been segmented into cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas, and others.

By material, the global market for cannula has been segmented into plastic (PVC), silicone, and metal (stainless steel).

By application, the global market for cannula has been segmented into cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopaedic surgery, and others.

By the end-user, the global market for cannula has been segmented into hospitals, ambulatory surgical centers, and others. The hospital segment is expected to dominate market share due to an increase in hospitalizations and a significant number of hospital surgeries. Ambulatory surgical centers are expected to increase at the highest level of CAGR due to the increasing demand for modern healthcare facilities.

 

Region-wise, the global market for cannula has been segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa

The Americas are expected to dominate the global cannula market due to increasing healthcare expenditure, expanding the number of surgeries, and improving healthcare infrastructure. According to Centers Medicare and Medicaid Services, National Health Care Expenditure increased from the previous year by 4.3% to USD 3.3 trillion in 2016.

Europe is set to retain the second-largest position on the global cannula market. Market growth in this area is due to government support and the advancement of research and development related to healthcare activities.

The Cannula Market in the Asia Pacific region comprises countries such as China, the Republic of Korea, Japan, India, Australia, and the rest of the Asia Pacific. The Asia Pacific region is anticipated to witness the fastest growing region owing to the massive demand for minimally invasive surgeries and increasing healthcare spending. According to the World Bank Group, India spent 3.89% of its Gross Domestic Product (GDP) on health.

The Middle East and Africa are predicted to have the least market share. Market growth in this area is anticipated to be driven by the development of healthcare infrastructure.

 

Cannula Market Key players

Some of the significant participants in the global cannula market are Medtronic, Edwards Lifesciences Corporation, Teleflex Incorporated, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Smith & Nephew, Smiths Medical, Boston Scientific Corporation, CONMED Corporation, Harsoria Healthcare Pvt. Ltd., ISPG Inc., ILIFE MEDICAL DEVICES PRIVATE LIMITED (INDIA), McKesson Medical-Surgical Inc., Denex International, BD, and others.

 

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/cannula-market-6937 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Anti-viral drugs Market Growth Is Driven By The Increasing Demands of Various Therapies and Geographical Regions

 Anti-viral Drugs Market Highlights 

The global anti-viral drugs market is likely to touch an impressive valuation of USD 62.67 billion by 2022, predicts Market Research Future (MRFR). The report published by MRFR on the global anti-viral drugs market mentions that the market is projected to register a CAGR of 6.9% between 2013 and 2022.

Download Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454 



Anti-viral Drugs Market Key Players

MRFR have enlisted some of the prominent companies operating in the anti-viral drugs market. They are; Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Cipla Inc. GlaxoSmithKline Plc, Novartis International AG, Abbott Laboratories, and  Astra Zeneca AB.  

Anti-viral Drugs Market Synopsis

The rising cases of viral disease is identified to boost the global anti-viral drugs market growth. The inadequacy of dietary nutrition in people, due to increase in consumption of high calorie and low fibrous food is creating favourable condition for virus to invade human body. Hence, the need for anti-viral drugs are surging as viral infections prevail. The growing incidences of HIV and other sexually-transmitted diseases are also boosting the sales number of anti-viral drugs, hence, anticipated to prompt the anti-viral drug market growth.

The increase in cases of drug resistance is propelling extensive research and developmental undertakings for launching more effective anti-viral drugs. Additionally, the stringency in drug approval stages are taking care of the quality of drugs in the pipeline. New product launches are gaining traction for revenue generation for the anti-viral drugs market. The application of anti-viral drugs in other diseases like, bird flu, and others is also likely to prompt the global anti-viral drug growth. 

The expiry of patents for certain blockbuster anti-viral drug are stimulating generic drug competition in the anti-viral drug market. This is deepening the competitive scenario of the global anti-viral drug market over the assessment period. 

However, adverse effects of anti-viral drugs and high price of anti-viral drugs can hinder the anti-viral drugs market growth over the assessment period.  

Anti-viral Drugs Market Segmental Overview

The global anti-viral drugs market study has been segmented on the basis of application and mechanism of action.

Based on the application, the anti-viral drugs market has been segmented into Influenza, Hepatitis, Herpes, HIV/AIDS, and others. 

Based on the mechanism of action, the anti-viral drugs market has been segmented into Protease Inhibitors, Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, and others. 

Anti-viral Drugs Market Regional Outlook

Based on the region, the anti-viral drug market has been studied across the Americas, Asia Pacific, Europe, and the Middle East Asia.

MRFR forecasts that the anti-viral drug market in the American region is likely to hold the largest market share. The need for effective treatment of diseases due to the growing cases of viral infection in the region can bolster the anti-viral drugs market. The North American market is expected to grasp greater than 30% of the global market share. The anti-viral drugs market in Europe is likely to garner an impressive CAGR by 2022. MRFR report states that the anti-viral drugs market in Europe will hold the second largest market share over the review period. The anti-viral drug market in the Asia pacific region anticipated to register the highest CAGR over the forecast period. The anti-viral drug market in the Middle East Asia and Africa is expected to exhibit a sluggish growth. 

Browse Complete Report with Covid19 Impact @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

 

Augmented Reality in Healthcare Market 2020 Global Size, Share, Technology Trends, Growth Opportunities, Top Company Analysis

Global Augmented Reality in Healthcare Market Report, Trends, Growth, Size and Industry Analysis by Component (Hardware, Software), Device Type (Head-Mounted Display), Application (Fitness Management) – Forecast till 2023

Augmented Reality in Healthcare Market Overview

MRFR has asserted that Augmented Reality in Healthcare Market growth is likely to achieve a valuation of USD 1.32 Bn at a dynamic CAGR of 23% by 2023.

The application of augmented reality in healthcare is still in its nascent stage but has shown signs of potentials to improve clinical outcomes. Market Research Future (MRFR) has thoroughly studied the trends and patterns governing the global augmented reality in the healthcare market over the forecast period of 2017-2023 in an extensive study. 

The application of augmented reality in healthcare has uncovered many new opportunities in the healthcare sector. Augmented reality in healthcare can assist doctors in diagnosing, treating, and performing surgeries with enhanced efficiency. The growth of the market stems from the increasing penetration of smart connected devices in the healthcare sector. Moreover, the rise in surgeries using laparoscopy, endoscopy, catheterized intervention has further paved d the way of the expansion of the market. The medical application of augmented reality is being vigorously studied by researchers which coupled with high investment from various governments is expected to propel the market. Advances in advances in camera and sensor technology and AR-focused software research is likely to expedite the growth of the market in the coming years. Other factors contributing to the market growth include high healthcare expenditure and application of augmented reality in medical training, pharmacy benefit management, and patient education. 

On the other hand, lack of proper infrastructure to incorporate augmented reality in healthcare, especially in developing countries is likely to hinder the growth of the market. Additionally, lack of technical know-how and reluctance among medical practitioners to adopt new technologies might constrain the growth of the market over the forecast period. Moreover, high costs associated with it, limited functionality, and perception problems are other bottlenecks to the growth of the market. 

Augmented Reality in Healthcare Market Segmentation

Global augmented reality in healthcare market has been segmented based on device type, component, and application.

By device, the augmented reality in healthcare market has been segmented into handheld device, head-mounted display, and others. 

By component, the augmented reality in healthcare market has been segmented into software, hardware, and others. 

By application, the augmented reality in healthcare market has been segmented into medical training, fitness management, and education, among others. 

Augmented Reality in Healthcare Market Regional Analysis

By region, the augmented reality in healthcare market has been segmented into North America, Asia Pacific (APAC), Europe, and Rest-of-the-World (RoW). 

North America is the largest augmented reality in healthcare market share. A robust healthcare infrastructure in the region supports the growth of the market. Moreover, the region is a frontrunner in the adoption of latest technologies due to which augmented reality has gained widespread acceptance among healthcare professionals. High healthcare expenditure and technological advances in the field has further supported the market growth. Moreover, the presence of various market players in the region favors market growth. 

Europe is an important revenue pocket for the augmented reality in healthcare market. Increasing healthcare expenditure along with changing healthcare policies is expected to foster the growth of the market. 

The APAC augmented reality in healthcare market report is likely to be driven by rapid technological adoption in the developing economies of the region. Moreover, fast track economic progress and improvements in healthcare infrastructure have the potential to trigger growth within the market. The APAC market is estimated to register the highest CAGR over the forecast period. 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/augmented-reality-in-healthcare-market-5236

Augmented Reality in Healthcare Market Competitive Landscape

Osterhout Design Group (U.S.), Virtually Better (U.S.), DAQRI (U.S.), Blippar (U.K), VirtaMed (Switzerland), Wikitude GmbH (Austria), Microsoft Corporation (U.S.), CAE Healthcare (U.S.),

Google LLC. (U.S.), Augmedix (U.S.), Oculus VR (U.S.), Magic Leap, Inc. (U.S.), HTC (Taiwan),

Philips Healthcare (Netherlands & U.S.), 3D Systems (U.S.), Medical Realities (U.K), Mindmaze (Switzerland), Atheer (U.S.), Siemens Healthineers (Germany) are the distinguished companies in augmented reality in healthcare market.

Augmented Reality in Healthcare Industry Updates

March 2019 - Koninklijke Philips N.V., a Dutch company dedicated to creating the future of healthcare, and Microsoft Corporation, the global technology giant, have jointly developed an augmented reality concept for image-guided minimally invasive surgeries. The concept is based on Philips’ Azurion image-guided therapy platform and Microsoft’s HoloLens 2 holographic computing platform. 

Biosimilars Market Comprehensive Analysis, Trends, Growth and Demand

 Atrial Fibrillation Market Overview:

Rapid technological advancement is aiding the healthcare sector for the development of advanced medical devices to treat various complex health conditions. Atrial fibrillation is a medical condition where the heartbeats are irregular which increases the risk of stroke, heart failure, blood clots and other heart-related complications. This condition may sometime require surgical treatments such as ablation, pacemakers and others. Market Research Future (MRFR) has published a detailed report stating that the global atrial fibrillation market is marked to expand at a notable growth rate during the forecast period of 2017-2023.

 

Get request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6520 

 

Atrial Fibrillation Market Drivers and Restraints:

Increasing prevalence of atrial fibrillation owing to the factors such as high alcohol consumption, hypertension and other chronic diseases, changing lifestyle and rise in geriatric population are majorly fueling the growth of the global atrial fibrillation market. Rapid adoption of advanced technology in the healthcare sector in order to improve the diagnostic and treatment procedures and availability of high-resolution images that can be obtained for proper diagnosis of heart conditions are propelling the growth of the global atrial fibrillation market. Increased research and development in the healthcare sector in various regions is also driving the expansion of the global atrial fibrillation market. However, absence of primary healthcare services and low penetration of advanced technology in the underdeveloped countries are likely to restrain the expansion of the global atrial fibrillation market during the forecast period.

 

Atrial Fibrillation Market Segmentation:

The global atrial fibrillation market has been segmented on the basis of product and end-users. Based on product, the atrial fibrillation market has been segmented into non-surgical and surgical. Based on end-users, the global atrial fibrillation market has been segmented into cardio centers, big hospitals, and heart specialty care enterprises. The heart specialty care enterprises segment commands the major share in the global atrial fibrillation market.

 

Atrial Fibrillation Market Regional Analysis:

Geographically, the global atrial fibrillation market has been segmented into four major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas project significant growth in the global atrial fibrillation market owing to the increasing prevalence of heart conditions as a result of changing lifestyle, busy work culture and unhealthy dietary habits of the population in this region. Easy adoption of technologically advanced treatment solutions in the well-developed healthcare sector is also propelling the growth of the atrial fibrillation market in this region. Increased research and development expenditure for introduction of advanced treatment and diagnosis techniques is fueling the growth of the atrial fibrillation market in the Europe region. Rise in prevalence of individuals suffering from atrial fibrillation and development of healthcare sector in the emerging economies are aiding the growth of the atrial fibrillation market in the Asia Pacific region. The Middle East and Africa region is anticipated to project sluggish growth in the global atrial fibrillation market owing to the lack of primary healthcare services and poor economic conditions in the underdeveloped areas of this region.

 

Industry Updates:

In November 2018, Johnson and Johnson Medical Devices Company has announced that Biosense Webster Inc. has successfully treated the first patient in its STELLAR U.S. Investigational Device Exemption (IDE) study that has been carried out to evaluate safety and effectiveness of Heliostar Multi-electrode Radiofrequency balloon ablation catheter in treating atrial fibrillation. 

 

In December 2018, it has been announced the first patient has been treated in the TERMINATE AF study for evaluation of Cardioblate Irrigated RF System of Medtronic and also its CryoFlex Surgical Ablation System for the patients with persistent atrial fibrillation that are undergoing open heart surgery. 

 

Key Players:

The prominent players profiled by MRFR that are operating in the global atrial fibrillation market are Biosense Webster, Carima, Agricore, Medtronic, and St. Jude Medical.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/atrial-fibrillation-systems-market-6520 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.